Preclinical study indicates that morpholino-mediated FOXP3 isoform shifting is a potentially promising immunotherapeutic approach for cancer treatment.

In GEN’s flagship virtual event, The State of Biotech, outstanding research and business leaders from industry and academia will discuss the latest research developments, innovations, new ...

In this GEN webinar, Joe Guiles, PhD, will describe an enhanced two-step oligonucleotide purification process using strong anion exchange with ion-pair reversed-phase (AX-IPRP) chromatography.

Stem cells cryopreserved on the International Space Station for six months have successfully produced healthy mouse offspring.

BioMADE’s investment in Iowa is expected to provide access to the technology infrastructure required to determine if a product is commercially viable.

Made Scientific's new facility opening marks the completion of a $12 million initial investment in facility upgrades and equipment.

The enhanced hybrid model improves the predictive capability of data-driven modeling and reduces the need for process knowledge.

Data from a new study elucidates the role of a transcriptional enhancer dubbed HAR123 in neural cell development and cognitive flexibility.

An oxygen-generating implant keeps high-density insulin-producing cells alive in diabetic rats for months without immune suppression.

Bioprocessing experts have a terrific opportunity to use generative AIs for applications like quality assurance, but it’s important to know their limitations. That’s the view of Colin Zick, a ...

Top 10 U.S. Biopharma Clusters 2025 Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.